跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Appesaph
Approved
STANDARD
Appesaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0893d17a22859884
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
0893d17a22859884
Drug Approval Philippines Name
Appesaph
Product Name
Appesaph
Registration Number
DRP-9439
Brand Name
Appesaph
Generic Name
Multivitamins + Buclizine HCl + Iron
Dosage Form
Capsule
Dosage Strength
Each Capsule contains Thiamine Mononitrate (Vitamin B1)-10mg Pyridoxine HCl (Vitamin B6)-5mg Cyanocobalamin (Vitamin B12)-10mcg Buclizine HCI-25mg Iron-25mg (equivalent to 76.06 mg Ferrous Fumarate)
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
25 January 2021
Expiry Date
25 January 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0893d17a22859884
Type
Standard
Back to Philippines FDA Approvals
Appesaph - Philippines FDA Drug Approval Details